Earnings Ahead

ANAB - AnaptysBio, Inc.

20.49 0.3 1.49

AnaptysBio, Inc.

AnaptysBio, Inc.

About

Profile


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ANAB



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • AnaptysBio GAAP EPS of -$1.18 misses by $0.56, revenue of $1.29M misses by $12.14M
  • AnaptysBio raised to Buy at Guggenheim on prospects for checkpoint agonists
  • AnaptysBio benefits from results of GSK mid-stage Jemperli combo lung cancer trial
  • GSK Jemperli meets main goal of phase 2 trial to treat lung cancer
  • AnaptysBio cut to Hold at Truist citing high bar for hair loss treatment
  • AnaptysBio sells royalties from GSK-partnered Zejula for $45M
  • AnaptysBio skin condition candidate fails mid-stage trial; shares down 16%
  • AnaptysBio GAAP EPS of -$1.15 misses by $0.14, revenue of $1.21M misses by $4.4M
  • AnaptysBio GAAP EPS of -$1.31 misses by $0.32, revenue of $0.97M misses by $4.08M
  • AnaptysBio cut to neutral at Guggenheim on future of pipeline
  • AnaptysBio names interim CEO as Hamza Suria steps down
  • AnaptysBio acne treatment imsidolimab fails in mid-stage trial; shares down 12%
  • AnaptysBio GAAP EPS of -$1.18, revenue of $1.01M
  • AnaptysBio EPS beats by $0.64, beats on revenue
  • AnaptysBio climbs 14%, will monetize portion of JEMPERLI royalties for $250M with Sagard
  • AnaptysBio reports updated data from imsidolimab mid-stage study in pustular psoriasis
  • ANAB, TLRY, PFMT and BMRN among after hours movers
  • AnaptysBio secures $20M milestone payment from GSK after JEMPERLI FDA approval
  • AnaptysBio EPS beats by $0.12, beats on revenue
  • AnaptysBio gains after report the company received a takeover offer
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
November 4, 2021 -0.24 / -0.8503 20.89M / 6.65M Beat!
August 9, 2021 -0.02 / -0.1028 30.03M / 28.88M Beat!
May 4, 2021 -0.66 / -0.6883 11.25M / 9.39M Beat!
February 25, 2021 1.2 / 1.94 60M / 80M
November 4, 2020 -0.87 / -0.7217 - / -
August 10, 2020 -0.79 / -0.75 - / 1.88M
May 6, 2020 -0.3 / -0.63 15M / 7.71M Beat!
March 2, 2020 -0.75 / -1.2 3M / 2.25M Beat!
November 8, 2019 -1.15 / -1.15 3.00M / 3.11M
August 8, 2019 -0.89 / -0.99 5M / 2.55M Beat!
May 7, 2019 -0.82 / -0.83 5.00M / 2.43M Beat!
February 28, 2019 -0.64 / -0.91 5.00M / 218.75K
November 8, 2018 -0.66 / -0.71 5M / 291.67K
August 7, 2018 -0.57 / -0.69 1.63M / 1.63M
May 8, 2018 -0.63 / -0.44 1.75M / 1.75M
November 9, 2017 -0.45 / -0.48 - / -
August 10, 2017 -0.13 / -0.48 7.00M / - Beat!
Date Price Open High Low Vol Change ER
Aug 7, 2023 18.46 18.83
19.33
18.28
202K -1.34%
Aug 4, 2023 18.71 19.12
19.43
18.52
151K -2.09%
Aug 3, 2023 19.11 20.13
20.38
19.08
130K -5.82%
Aug 2, 2023 20.29 20.35
20.54
19.66
181K -1.31%
Aug 1, 2023 20.56 19.6
20.75
19.49
293K 4.31%
 
Jul 31, 2023 19.71 17.21
19.71
17.03
491K 15.13%
Jul 28, 2023 17.12 16.88
17.16
16.78
271K 2.27%
Jul 27, 2023 16.74 17.19
17.19
16.66
122K -1.88%
Jul 26, 2023 17.06 17.56
17.68
16.86
167K -3.12%
Jul 25, 2023 17.61 17.57
17.85
17.22
115K -0.45%
Jul 24, 2023 17.69 18.21
18.38
17.26
239K -2.37%
Jul 21, 2023 18.12 18.72
18.89
17.96
182K -2.53%
Jul 20, 2023 18.59 19.07
19.07
18.5
185K -2.16%
Jul 19, 2023 19 19.53
19.57
18.8
364K -1.96%
Jul 18, 2023 19.38 18.73
20.3
18.58
155K 3.25%
Jul 17, 2023 18.77 18.58
19.13
18.53
146K 1.62%
Jul 14, 2023 18.47 18.52
18.69
18
396K -0.7%
Jul 13, 2023 18.6 20.58
20.8
18.6
161K -9.4%
Jul 12, 2023 20.53 20.22
20.57
19.99
73.6K 2.65%
Jul 11, 2023 20 20.5
20.5
19.65
97.5K -2.68%
Jul 10, 2023 20.55 20.3
20.68
20.2
138K 1.68%
Jul 7, 2023 20.21 20.04
20.45
20.04
105K 0.35%
Jul 6, 2023 20.14 19.49
20.33
19.24
132K 3.23%
Jul 5, 2023 19.51 19.63
19.71
19.18
113K -0.56%
Jul 3, 2023 19.62 20.22
20.27
19.5
91.6K -3.54%
Jun 30, 2023 20.34 20.39
20.73
20.27
148K 0.39%
Jun 29, 2023 20.26 20.74
20.86
19.85
192K -2.64%
Jun 28, 2023 20.81 20.53
20.92
20.33
191K 1.56%
Jun 27, 2023 20.49 20.29
20.58
19.87
151K 1.49%
Jun 26, 2023 20.19 20.27
20.42
19.77
188K -0.25%
Jun 23, 2023 20.24 19.92
20.36
19.88
826K 1.05%
Jun 22, 2023 20.03 19.86
20.08
19.71
171K 0.65%
Jun 21, 2023 19.9 19.29
19.94
18.85
185K 3.11%
Jun 20, 2023 19.3 18.75
19.36
18.38
227K 2.93%
Jun 16, 2023 18.75 19.11
19.12
18.46
638K -0.27%
Jun 15, 2023 18.8 18.52
19.03
18.45
133K 1.29%
Jun 14, 2023 18.56 18.95
19.38
18.3
167K -2.42%
Jun 13, 2023 19.02 18.89
19.25
18.8
177K 1.39%
Jun 12, 2023 18.76 18.95
19.18
18.22
190K 0.32%
Jun 9, 2023 18.7 18.28
18.76
18.01
242K 2.07%
Jun 8, 2023 18.32 18.72
18.9
18.2
136K -2.19%
Jun 7, 2023 18.73 18.79
18.94
18.54
142K -0.16%
Jun 6, 2023 18.76 18.81
19.02
18.64
157K -0.27%
Jun 5, 2023 18.81 18.51
19.05
18.47
264K 0.48%
Jun 2, 2023 18.72 18.55
18.8
18.06
159K 1.30%
Jun 1, 2023 18.48 19.05
19.26
18.39
129K -3.25%
May 31, 2023 19.1 18.65
19.33
18.5
211K 2.96%
May 30, 2023 18.55 18.61
19
18.4
103K -0.54%
May 26, 2023 18.65 18.59
18.72
18.32
90.3K 0.05%
May 25, 2023 18.64 18.89
18.89
18.43
150K -1.53%
May 24, 2023 18.93 19.36
19.43
18.69
100K -3.07%
May 23, 2023 19.53 19.88
20.37
19.52
119K -2.25%
May 22, 2023 19.98 20.14
20.32
19.54
147K 4.44%
May 19, 2023 19.13 19.13
19.45
18.8
139K 1.06%
May 18, 2023 18.93 19.32
20.36
18.58
154K -0.63%
May 17, 2023 19.05 18.68
19.22
18.03
170K 2.25%
May 16, 2023 18.63 19.07
19.74
18.44
214K -3.82%
May 15, 2023 19.37 19.45
19.95
19.05
158K -0.41%
May 12, 2023 19.45 20.75
21.01
19
201K -6.31%
May 11, 2023 20.76 21.35
21.76
20.41
108K 0%